Trial Of Novavax COVID-19 Vaccine Begins In The United States

Phase 3 clinical trial of the COVID-19 vaccine NVX-CoV2373 developed by Novavax will begin in the United States and Mexico and enroll 30,000 participants.

from Medindia Health News https://ift.tt/3rN8Vqw